Patients | 223 |
Mean age at implant | 64.1±10.9 years |
Mean age at SF-36 | 71.1±9.7 years |
Females | 40 (17.9%) |
Device type | |
ICD-VR | 36 (16.1%) |
ICD-DR | 112 (50.2%) |
CRT-D | 75 (33.6%) |
Hypertension | 104 (46.6%) |
Diabetes mellitus | 47 (21.1%) |
Renal failure* | 27 (12.1%) |
Atrial fibrillation | 62 (27.8%) |
Beta-blockers | 201 (90.1%) |
ACE-i/ARB | 193 (86.5%) |
MRA | 104 (46.6%) |
Data presented as frequencies (percentage in parenthesis).
*Defined as S-creatinine≥130 μmol/L.
ACE-i, ACE inhibitor; ARB, angiotensin receptor blockers; CRT-D, cardiac resynchronisation therapy defibrillator; ICD-DR, dual lead implantable cardioverter defibrillator; ICD-VR, single lead implantable cardioverter defibrillator; MRA, mineralcorticoid receptor antagonist; SF-36, short form 36.